The consequences of DSM-5 for psychiatric diagnosis and psychopharmacotherapy

References

• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
   Google Scholar
• Andreasen NC. 2007. DSM and the death of phenomenology in america: an example of unintended consequences. Schizophr Bull 33:108–112.
   PubMed Web of Science ®Google Scholar
• Andrews G, Brugha T, Thase ME, Duffy FF, Rucci P, Slade T. 2007. Dimensionality and the category of major depressive episode. Int J Methods Psychiatr Res 16 Suppl 1:S41–S51.
   Google Scholar
• Angst J. 2013. Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord 1:12.
   Google Scholar
• Berk M. 2013. The DSM-5: Hyperbole, Hope or Hypothesis?BMC Med 11:128.
   Google Scholar
• Blazer D. 2013. Neurocognitive disorders in DSM-5. Am J Psychiatry 170:585–587.
   PubMed Web of Science ®Google Scholar
• Blennow K, Hampel H, Weiner M, Zetterberg H. 2010. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131–144.
   PubMed Web of Science ®Google Scholar
• Cermolacce M, Sass L, Parnas J. 2010. What is bizarre in bizarre delusions?A critical review. Schizophr Bull 36:667–679.
   PubMed Web of Science ®Google Scholar
• Clarke DE, Narrow WE, Regier DA, Kuramoto SJ, Kupfer DJ, Kuhl EA, et al. 2013. DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry 170:43–58.
   PubMed Web of Science ®Google Scholar
• Cuthbert BN, Insel TR. 2013. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11:126.
   PubMed Web of Science ®Google Scholar
• Dimsdale JE. 2013. Somatic Symptom Disorders: a new approach in DSM-5. Die Psychiatrie 10:30–32.
   Google Scholar
• Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. 2011. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci 34:430–442.
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, et al. 2008. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165:342–351.
   PubMed Web of Science ®Google Scholar
• Fawcett J. 2010. An overview of mood disorders in the DSM-5. Curr Psychiatry Rep 12:531–538.
   PubMedGoogle Scholar
• Fawcett J. 2013. Affective Disorders in DSM-5. Die Psychiatrie 10:18–23.
   Google Scholar
• Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, et al. 2010. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560–574.
   PubMed Web of Science ®Google Scholar
• Hyman SE. 2008. Can neuroscience be integrated into the DSM-V?Nat Rev Neurosci 8:725–732.
   Google Scholar
• Insel T. Director's Blog: Transforming Diagnosis. Available from: http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml.
   Google Scholar
• Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. 2010. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167:748–751.
   PubMed Web of Science ®Google Scholar
• Jager M, Haack S, Becker T, Frasch K. 2011. Schizoaffective disorder–an ongoing challenge for psychiatric nosology. Eur Psychiatry 26:159–165.
   PubMed Web of Science ®Google Scholar
• Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, Moller HJ, Riecher-Rossler A. 2012. Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull 38:1234–1246.
   PubMed Web of Science ®Google Scholar
• Maier W, Zobel A, Wagner M. 2006. Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry 19:165–170.
   PubMed Web of Science ®Google Scholar
• Maj M. 2013. Mood Disorders in ICD-11 and DSM-5. Die Psychiatrie 10:24–29.
   Google Scholar
• Moller HJ. 2005. Problems associated with the classification and diagnosis of psychiatric disorders. World J Biol Psychiatry 6:45–56.
   PubMed Web of Science ®Google Scholar
• Moller HJ. 2008a. The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition. Eur Arch Psychiatry Clin Neurosci 258:7–17.
   PubMedGoogle Scholar
• Moller HJ. 2008b. Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond. Eur Arch Psychiatry Clin Neurosci 258:48–73.
   PubMedGoogle Scholar
• Moller HJ. 2009a. Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge. Psychiatry Clin Neurosci 63:595–612.
   PubMed Web of Science ®Google Scholar
• Moller HJ. 2009b. Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales. World J Biol Psychiatry 10:6–26.
   PubMed Web of Science ®Google Scholar
• Moller HJ. In Press. Dichotomy versus spectrum concept in approaching psychotic disorders: are we ready to make the final decision? In: Soldatos C, Ruiz P, Dikeos D, Riba M, editors. Proceedings of the WPA Thematic Conference on Intersectional Collaboration 4th European Congress of INA and the 1st Interdisciplinary Congress of HSAPRS, Athens, Greece, Nov 29 to Dec 2, 2012. Pianoro, Italy: Medimond s.r.l.
   Google Scholar
• Narrow WE, Clarke DE, Kuramoto SJ, Kraemer HC, Kupfer DJ, Greiner L, Regier DA. 2013. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry 170:71–82.
   PubMed Web of Science ®Google Scholar
• Nordgaard J, Arnfred SM, Handest P, Parnas J. 2008. The diagnostic status of first-rank symptoms. Schizophr Bull 34:137–154.
   PubMed Web of Science ®Google Scholar
• Nusslock R, Frank E. 2011. Subthreshold bipolarity: diagnostic issues and challenges. Bipolar Disord 13:587–603.
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, et al. 2013. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 18:332–339.
   PubMed Web of Science ®Google Scholar
• Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, et al. 2010. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?Depress Anxiety 27:528–555.
   PubMed Web of Science ®Google Scholar
• Regier DA, Kuhl EA, Kupfer DJ. 2013a. The DSM-5: Classification and criteria changes. World Psychiatry 12:92–98.
   PubMed Web of Science ®Google Scholar
• Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, Kupfer DJ. 2013b. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 170:59–70.
   PubMed Web of Science ®Google Scholar
• Seemuller F, Riedel M, Obermeier M, Schennach-Wolff R, Spellmann I, Meyer S, et al. 2012. The validity of self-rated psychotic symptoms in depressed inpatients. Eur Psychiatry 27:547–552.
   Google Scholar
• Severus E, Bauer M. 2013. Diagnosing bipolar disorders in DSM-5. Int J Bipolar Disord 1:14.
   PubMedGoogle Scholar
• Stahl SM. 2013. The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses. CNS Spectr 18:65–68.
   PubMed Web of Science ®Google Scholar
• Starcevic V, Portman ME. 2013. The status quo as a good outcome: How the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria. Aust N Z J Psychiatry 47:995–997.
   Google Scholar
• Tandon R. 2012. The nosology of schizophrenia: toward DSM-5 and ICD-11. Psychiatr Clin North Am 35:557–569.
   PubMed Web of Science ®Google Scholar
• Tandon R, Carpenter WT. 2013. Psychotic disorders in DSM-5. Die Psychiatrie 10:5–9.
   Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28–40.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Classification of Diseases, 10th Revision (ICD-10) [Internet]. Geneva: World Health Organization. Available from: http://apps.who.int/classifications/icd10/browse/2010/en
   Google Scholar